-
Ferozsons Laboratories’ subsidiary BF Biosciences launches human insulin
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) has successfully launched a human insulin under the brand name ‘Ferulin’. The development was shared by Ferozsons Laboratories Limited, the parent company of BFBL, in its notice to the Pakistan Stock Exchange (PSX) on Thursday. “We are pleased to inform you that BF Biosciences Limited, a subsidiary of…
-
Pakistan’s pharma company BF Biosciences looks to raise at least Rs1.38bn through IPO
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) is planning an initial public offering (IPO) at the Pakistan Stock Exchange (PSX) with an aim to raise at least Rs1.375 billion ($4.94 million) through the issuance of 25 million shares at a floor price of Rs55 per share. Brokerage house Arif Habib Limited has been appointed as…
-
BF Biosciences gets DRAP nod for brownfield expansion
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for brownfield expansion. The development was shared by its parent Ferozsons Laboratories Limited in a notice to the Pakistan Stock Exchange (PSX) on Monday. “We are pleased to inform that BF Biosciences Limited, a subsidiary of Ferozsons…